Show simple item record

dc.contributor.authorGarcia, Santiago
dc.contributor.authorAlbaghdadi, Mazen S.
dc.contributor.authorMeraj, Perwaiz M.
dc.contributor.authorSchmidt, Christian
dc.contributor.authorGarberich, Ross
dc.contributor.authorJaffer, Farouc A.
dc.contributor.authorDixon, Simon
dc.contributor.authorRade, Jeffrey J
dc.contributor.authorTannenbaum, Mark
dc.contributor.authorChambers, Jenny
dc.contributor.authorHuang, Paul P.
dc.contributor.authorHenry, Timothy D.
dc.date2022-08-11T08:08:11.000
dc.date.accessioned2022-08-23T15:45:55Z
dc.date.available2022-08-23T15:45:55Z
dc.date.issued2020-04-10
dc.date.submitted2020-04-14
dc.identifier.citation<p>Garcia S, Albaghdadi MS, Meraj PM, Schmidt C, Garberich R, Jaffer FA, Dixon S, Rade JJ, Tannenbaum M, Chambers J, Huang PP, Henry TD. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Pandemic. J Am Coll Cardiol. 2020 Apr 9:S0735-1097(20)34913-5. doi: 10.1016/j.jacc.2020.04.011. Epub ahead of print. PMID: 32283124. <a href="https://doi.org/10.1016/j.jacc.2020.04.011">Link to article on publisher's site</a></p>
dc.identifier.issn0735-1097 (Linking)
dc.identifier.doi10.1016/j.jacc.2020.04.011
dc.identifier.pmid32283124
dc.identifier.urihttp://hdl.handle.net/20.500.14038/27638
dc.description.abstractThe COVID-19 Pandemic has significantly impacted the US healthcare system. To preserve resources, including personal protective equipment (PPE) and hospital beds to care for COVID-19 patients, the Centers for Disease Control and Prevention (CDC) recommended deferral of elective cardiac procedures (1), including coronary angiography and percutaneous coronary intervention for stable coronary artery disease. Timely reperfusion by means of primary percutaneous coronary intervention (PPCI) is the standard of care for STEMI patients (2). The Society for Cardiac Angiography and Interventions (SCAI) and American College of Cardiology (ACC) continue to recommend PPCI as the standard treatment of STEMI patients during the current pandemic (3). However, anecdotal reports suggest a decline in PPCI volumes in the US and around the world (4). To determine if a decrease in PPCI is occurring in the US in the COVID-19 era, we analyzed and quantified STEMI activations for 9 high-volume ( over 100 PPCI per year) cardiac catheterization laboratories in the US from January 1, 2019 to March 31, 2020.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=32283124&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://doi.org/10.1016/j.jacc.2020.04.011
dc.subjectST-elevation myocardial infarction
dc.subjectCOVID-19
dc.subjectCardiology
dc.subjectCardiovascular Diseases
dc.subjectInfectious Disease
dc.subjectVirus Diseases
dc.titleReduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Pandemic
dc.typeJournal Article
dc.source.journaltitleJournal of the American College of Cardiology
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/covid19/9
dc.identifier.contextkey17361305
html.description.abstract<p>The COVID-19 Pandemic has significantly impacted the US healthcare system. To preserve resources, including personal protective equipment (PPE) and hospital beds to care for COVID-19 patients, the Centers for Disease Control and Prevention (CDC) recommended deferral of elective cardiac procedures (1), including coronary angiography and percutaneous coronary intervention for stable coronary artery disease.</p> <p>Timely reperfusion by means of primary percutaneous coronary intervention (PPCI) is the standard of care for STEMI patients (2). The Society for Cardiac Angiography and Interventions (SCAI) and American College of Cardiology (ACC) continue to recommend PPCI as the standard treatment of STEMI patients during the current pandemic (3). However, anecdotal reports suggest a decline in PPCI volumes in the US and around the world (4).</p> <p>To determine if a decrease in PPCI is occurring in the US in the COVID-19 era, we analyzed and quantified STEMI activations for 9 high-volume ( over 100 PPCI per year) cardiac catheterization laboratories in the US from January 1, 2019 to March 31, 2020.</p>
dc.identifier.submissionpathcovid19/9
dc.contributor.departmentDepartment of Medicine, Division of Cardiovascular Medicine


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record